Methotrexate, an anti-inflammatory drug, inhibits Hepatitis E viral replication

References

• Aggarwal R, Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol. 2009;24(9):1484–1493.
   PubMed Web of Science ®Google Scholar
• Koonin EV, Gorbalenya AE, Purdy MA, Rozanov MN, Reyes GR, Bradley DW. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc Natl Acad Sci U S A. 1992;89(17):8259–8263. doi: 10.1073/pnas.89.17.8259.
   Google Scholar
• Jeang KT, Yedavalli V. Role of RNA helicases in HIV-1 replication. Nucleic Acids Res. 2006;34(15):4198–4205.
   PubMed Web of Science ®Google Scholar
• Van De Garde MDB, Pas SD, Van Oord GW, Gama L, Choi Y, De Man RA, Boonstra A, Vanwolleghem T. Interferon-alpha treatment rapidly clears Hepatitis e virus infection in humanized mice. Sci Rep. 2017;7(1):8267.
   PubMedGoogle Scholar
• Chen CH, Yu ML. Evolution of interferon-based therapy for chronic hepatitis C. Hepat Res Treat. 2010;2010:140953–12.
   PubMedGoogle Scholar
• Nishikiori M, Sugiyama S, Xiang H, Niiyama M, Ishibashi K, Inoue T, Ishikawa M, Matsumura H, Katoh E. Crystal structure of the superfamily 1 helicase from tomato mosaic virus. J Virol. 2012;86(14):7565–7576.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang Y. I-TASSER server: new development for protein structure and function predictions. Nucleic Acids Res. 2015;43(W1):W174–W181.
   PubMed Web of Science ®Google Scholar
• Zheng W, Zhang C, Li Y, Pearce R, Bell EW, Zhang Y. Folding non-homologous proteins by coupling deep-learning contact maps with I-TASSER assembly simulations. Cell Rep Methods. 2021;1(3):100014.
   PubMedGoogle Scholar
• Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. The I-TASSER suite: protein structure and function prediction. Nat Methods. 2015;12(1):7–8.
   PubMed Web of Science ®Google Scholar
• Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583–589.
   PubMed Web of Science ®Google Scholar
• Roos K, Wu C, Damm W, Reboul M, Stevenson JM, Lu C, Dahlgren MK, Mondal S, Chen W, Wang L, et al. OPLS3e: extending force field coverage for drug-like small molecules. J Chem Theory Comput. 2019;15(3):1863–1874.
   PubMed Web of Science ®Google Scholar
• Blum M, Chang HY, Chuguransky S, Grego T, Kandasaamy S, Mitchell A, Nuka G, Paysan-Lafosse T, Qureshi M, Raj S, et al. The InterPro protein families and domains database: 20 years on. Nucleic Acids Res. 2021;49(D1):D344–D354.
   PubMed Web of Science ®Google Scholar
• Yang J, Roy A, Zhang Y. Protein-ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment. Bioinformatics. 2013;29(20):2588–2595.
   PubMed Web of Science ®Google Scholar
• Yang J, Roy A, Zhang Y. BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions. Nucleic Acids Res. 2013;41:D1096–D1103.
   PubMed Web of Science ®Google Scholar
• Zhang C, Freddolino PL, Zhang Y. COFACTOR: improved protein function prediction by combining structure, sequence and protein-protein interaction information. Nucleic Acids Res. 2017;45(W1):W291–W299.
   PubMed Web of Science ®Google Scholar
• McGreig JE, Uri H, Antczak M, Sternberg MJE, Michaelis M, Wass MN. 3DLigandSite: structure-based prediction of protein-ligand binding sites. Nucleic Acids Res. 2022;50(W1):W13–W20.
   PubMed Web of Science ®Google Scholar
• O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open babel: an open chemical toolbox. J Cheminform. 2011;3(10):33.
   PubMed Web of Science ®Google Scholar
• Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol. 2015;1263:243–250.
   PubMedGoogle Scholar
• Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013;27(3):221–234.
   PubMed Web of Science ®Google Scholar
• Rappe AK, Casewit CJ, Colwell KS, Goddard W, Skiff WM. UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations. J Am Chem Soc. 1992;114(25):10024–10035.
   Web of Science ®Google Scholar
• Krieger E, Joo K, Lee J, Lee J, Raman S, Thompson J, Tyka M, Baker D, Karplus K. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins: Structure, Function and Bioinformatics. 2009;77 Suppl 9(9):114–122.
   PubMedGoogle Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–461.
   PubMed Web of Science ®Google Scholar
• Emerson SU, Nguyen H, Graff J, Stephany DA, Brockington A, Purcell RH. In Vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein. J Virol. 2004;78(9):4838–4846.
   PubMed Web of Science ®Google Scholar
• Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossváry I, Moraes MA, Sacerdoti FD, et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. ACM/IEEE SC 2006 Conference (SC'06): International Conference for High Performance Computing, Networking, Storage and Analysis; 2006 Nov 11–17; Tampa, Florida. New York (USA): Association for Computing Machinery; 2006. p. 43.
   Google Scholar
• Huang YW, Haqshenas G, Kasorndorkbua C, Halbur PG, Emerson SU, Meng XJ. Capped RNA transcripts of full-length cDNA clones of swine hepatitis E virus are replication competent when transfected into Huh7 cells and infectious when intrahepatically inoculated into pigs. J Virol. 2005;79(3):1552–1558.
   PubMed Web of Science ®Google Scholar
• Hooda P, Ishtikhar M, Saraswat S, Bhatia P, Mishra D, Trivedi A, Kulandaisamy R, Aggarwal S, Munde M, Ali N, et al. Biochemical and biophysical characterisation of the hepatitis E virus guanine-7-methyltransferase. Molecules. 2022;27(5):1505.
   PubMed Web of Science ®Google Scholar
• Karpe YA, Lole KS. NTPase and 5′ to 3′ RNA duplex-unwinding activities of the hepatitis E virus helicase domain. J Virol. 2010;84(7):3595–3602.
   PubMed Web of Science ®Google Scholar
• Graves-Woodward KL, Gottlieb J, Challberg MD, Weller SK. Biochemical analyses of mutations in the HSV-1 helicase-primase that alter ATP hydrolysis, DNA unwinding, and coupling between hydrolysis and unwinding* [Internet]. [place unknown]. http://www-jbc.stanford.edu/jbc/.
   Google Scholar
• Kumar S, Kumar A, Mamidi P, Tiwari A, Kumar S, Mayavannan A, Mudulli S, Singh AK, Subudhi BB, Chattopadhyay S. Chikungunya virus nsP1 interacts directly with nsP2 and modulates its ATPase activity. Sci Rep. 2018;8(1):1045.
   PubMedGoogle Scholar
• White MA, Lin W, Cheng X. Discovery of COVID-19 inhibitors targeting the SARS-CoV-2 Nsp13 helicase. J Phys Chem Lett. 2020;11(21):9144–9151.
   PubMed Web of Science ®Google Scholar
• Saraswat S, Chaudhary M, Sehgal D. Hepatitis E virus cysteine protease has papain like properties validated by in silico mModeling and cell-free inhibition assays. Front Cell Infect Microbiol. 2019;9:478.
   PubMed Web of Science ®Google Scholar
• Nair V, Surjit M. RNA strand displacement assay for hepatitis E virus helicase. Bio Protoc. 2017;7(7):e2198.
   PubMedGoogle Scholar
• Keszei AFA, Sicheri F. Mechanism of catalysis, E2 recognition, & autoinhibition for the IPAH family of bacterial E3 ubiquitin ligases. Proc Natl Acad Sci USA. 2017;114(6):1311–1316.
   PubMed Web of Science ®Google Scholar
• Ewert W, Franz P, Tsiavaliaris G, Preller M. Structural and computational insights into a blebbistatin-bound myosin• ADP complex with characteristics of an ADP-release conformation along the two-step myosin power stoke. Int J Mol Sci. 2020;21(19):7417.
   PubMed Web of Science ®Google Scholar
• Trivedi A, Kardam V, Inampudi KK, Vrati S, Gupta D, Singh A, Kayampeta SR, Appaiahgari MB, Sehgal D. Identification of a novel inhibitor of SARS-CoV-2 main protease: an in silico, biochemical, and cell-based approach. FEBS J. 2023 Sep 1. doi: 10.1111/febs.16947. Epub ahead of print.
   Google Scholar
• Kumar M, Hooda P, Khanna M, Patel U, Sehgal D. Development of BacMam induced hepatitis E virus replication model in hepatoma cells to study the polyprotein processing. Front Microbiol. 2020;11:1347.
   PubMed Web of Science ®Google Scholar
• Gilhooly NS, Gwynn EJ, Dillingham MS. Superfamily 1 helicases. Front Biosci (Schol Ed). 2013;5(1):206–216. doi: 10.2741/s367.
   Google Scholar
• Chaudhary M, Sehgal D. In silico identification of natural antiviral compounds as a potential inhibitor of chikungunya virus non-structural protein 3 macrodomain. J Biomol Struct Dyn. 2022;40(22):11560–11570.
   PubMed Web of Science ®Google Scholar
• Parvez MK, Subbarao N. Molecular analysis and modeling of hepatitis e virus helicase and identification of novel inhibitors by virtual screening. Biomed Res Int. 2018;2018:5753804–5753808.
   PubMed Web of Science ®Google Scholar
• Tian L, Qiang T, Liang C, Ren X, Jia M, Zhang J, Li J, Wan M, YuWen X, Li H, et al. RNA-dependent RNA polymerase (RdRp) inhibitors: the current landscape and repurposing for the COVID-19 pandemic. Eur J Med Chem. 2021;213:113201.
   PubMed Web of Science ®Google Scholar
• Lipsitch M, Krammer F, Regev-Yochay G, Lustig Y, Balicer RD. SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact. Nat Rev Immunol. 2022;22(1):57–65.
   PubMed Web of Science ®Google Scholar
• Ranji A, Boris-Lawrie K. RNA helicases: emerging roles in viral replication and the host innate response. RNA Biol. 2010;7(6):775–787.
   PubMed Web of Science ®Google Scholar
• Ferron F, Decroly E, Selisko B, Canard B. The viral RNA capping machinery as a target for antiviral drugs. Antiviral Res. 2012;96(1):21–31.
   PubMed Web of Science ®Google Scholar
• Kumar S, Singh B, Kumari P, Kumar PV, Agnihotri G, Khan S, Kant Beuria T, Syed GH, Dixit A. Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity. Comput Struct Biotechnol J. 2021;19:1998–2017.
   PubMed Web of Science ®Google Scholar
• Ghahremanpour MM, Tirado-Rives J, Deshmukh M, Ippolito JA, Zhang CH, Cabeza De Vaca I, Liosi ME, Anderson KS, Jorgensen WL. Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2. ACS Med Chem Lett. 2020;11(12):2526–2533.
   PubMed Web of Science ®Google Scholar
• Calleja DJ, Lessene G, Komander D. Inhibitors of SARS-CoV-2 PLpro. Front Chem. 2022;10:876212.
   PubMed Web of Science ®Google Scholar
• El Hassab MA, Ibrahim TM, Al-Rashood ST, Alharbi A, Eskandrani RO, Eldehna WM. In silico identification of novel SARS-COV-2 2′-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches. J Enzyme Inhib Med Chem. 2021;36(1):727–736.
   PubMed Web of Science ®Google Scholar
• Loganathan L, Carlus SJ, Muthusamy K. In Silico analysis of drug repurposing strategy for the identification of potential NS3 helicase inhibitors against zika virus. CCS. 2021;1(3):373–385.
   Google Scholar
• Halim SA, Khan S, Khan A, Wadood A, Mabood F, Hussain J, Al-Harrasi A. Targeting dengue virus NS-3 helicase by ligand based pharmacophore modeling and structure based virtual screening. Front Chem. 2017;5:88.
   PubMed Web of Science ®Google Scholar
• Kleymann G, Fischer R, Betz UAK, Hendrix M, Bender W, Schneider U, Handke G, Eckenberg P, Hewlett G, Pevzner V, et al. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease. Nat Med. 2002;8(4):392–398.
   PubMed Web of Science ®Google Scholar
• Shiraki K, Yasumoto S, Toyama N, Fukuda H. Amenamevir, a helicase-primase inhibitor, for the optimal treatment of herpes zoster. Viruses. 2021;13(8):1547.
   PubMed Web of Science ®Google Scholar
• Gowda P, Patrick S, Joshi SD, Kumawat RK, Sen E. Repurposing methotrexate in dampening SARS-CoV2-S1-mediated IL6 expression: lessons learnt from lung cancer. Inflammation. 2022;45(1):172–179.
   PubMed Web of Science ®Google Scholar
• Caruso A, Caccuri F, Bugatti A, Zani A, Vanoni M, Bonfanti P, Cazzaniga ME, Perno CF, Messa C, Alberghina L. Methotrexate inhibits SARS-CoV-2 virus replication “in vitro. J Med Virol. 2021;93(3):1780–1785.
   PubMed Web of Science ®Google Scholar
• Visser K, Van Der Heijde D. Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature. Ann Rheum Dis. 2009;68(7):1094–1099.
   PubMed Web of Science ®Google Scholar